UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross‐sectional study

Clinical endocrinology (Oxford), 2023-02, Vol.98 (2), p.165-176

2023

Volltextzugriff (PDF)

Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?

Cancers, 2023-09, Vol.15 (19), p.4735

2023

Volltextzugriff (PDF)

Epidemiology and diagnosis of primary aldosteronism. What have we learned from the SPAIN-ALDO registry?

Endocrine, 2024-03, Vol.83 (3), p.527-536

2024

Volltextzugriff (PDF)

Radiological Knosp, Revised-Knosp, and Hardy-Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases

Frontiers in oncology, 2022-01, Vol.11, p.807040-807040

2022

Volltextzugriff (PDF)

Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study

Endocrine, 2021-08, Vol.73 (2), p.439-446

2021

Volltextzugriff (PDF)

Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?

Endocrine, 2023-10, Vol.82 (1), p.161-170

2023

Volltextzugriff (PDF)

Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases

Clinical and experimental medicine, 2022-08, Vol.22 (3), p.359-370

2022

Volltextzugriff (PDF)

Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients

Endocrine, 2020-12, Vol.70 (3), p.584-592

2020

Volltextzugriff (PDF)

Bronchial Carcinoids: From Molecular Background to Treatment Approach

Cancers, 2022-01, Vol.14 (3), p.520

2022

Volltextzugriff (PDF)

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance

Biomedicines, 2021-03, Vol.9 (3), p.304

2021

Volltextzugriff (PDF)

Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?

Frontiers in endocrinology (Lausanne), 2024-01, Vol.14, p.1335202-1335202

2024

Volltextzugriff (PDF)

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas

Endocrine Connections, 2021-01, Vol.10 (1), p.102-109

2021

Volltextzugriff (PDF)

The Dose of Somatostatin Analogues during Pre-Surgical Treatment Is a Key Factor to Achieve Surgical Remission in Acromegaly

Endocrines, 2021-08, Vol.2 (3), p.241-250

2021

Volltextzugriff (PDF)

Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity

Annales d'endocrinologie, 2023-04, Vol.84 (2), p.272-284

2023

Volltextzugriff (PDF)

Pituitary tumors: epidemiology and clinical presentation spectrum

Hormones (Athens, Greece), 2020-06, Vol.19 (2), p.145-155

2020

Volltextzugriff (PDF)

Clinical presentation and surgical outcomes of very large and giant pituitary adenomas: 80 cases in a cohort study of 306 patients with pituitary adenomas

Acta neurochirurgica, 2024-05, Vol.166 (1), p.225-225, Article 225

2024

Volltextzugriff (PDF)

The NETFIT trial: Smart wearable medical devices to assess the quality of life of patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13627-e13627

2023

Volltextzugriff (PDF)

Altered Concentrations in Dyslipidemia Evidence a Role for ANGPTL8/Betatrophin in Lipid Metabolism in Humans

The journal of clinical endocrinology and metabolism, 2016-10, Vol.101 (10), p.3803-3811

2016

Volltextzugriff (PDF)

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases

The journal of clinical endocrinology and metabolism, 2024-03

2024

Volltextzugriff (PDF)

Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

The journal of clinical endocrinology and metabolism, 2023-12, Vol.109 (1), p.e379-e388

2023

Volltextzugriff (PDF)

Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma

Journal of neuro-oncology, 2022-11, Vol.160 (2), p.351-359

2022

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(52)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross‐sectional study

Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?

Epidemiology and diagnosis of primary aldosteronism. What have we learned from the SPAIN-ALDO registry?

Radiological Knosp, Revised-Knosp, and Hardy-Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases

Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study

Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?

Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)

Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases

Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients

Bronchial Carcinoids: From Molecular Background to Treatment Approach

Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance

Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas

Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism

The Dose of Somatostatin Analogues during Pre-Surgical Treatment Is a Key Factor to Achieve Surgical Remission in Acromegaly

Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)

Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity

Pituitary tumors: epidemiology and clinical presentation spectrum

Clinical presentation and surgical outcomes of very large and giant pituitary adenomas: 80 cases in a cohort study of 306 patients with pituitary adenomas

The NETFIT trial: Smart wearable medical devices to assess the quality of life of patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET)

Altered Concentrations in Dyslipidemia Evidence a Role for ANGPTL8/Betatrophin in Lipid Metabolism in Humans

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases

Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma

Suchergebnisse filtern